Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of Hydroxychloroquine in Patients With Solid Tumors Receiving Radiotherapy for Bone Metastases

NCT01417403 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT01417403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01417403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of Hydroxychloroquine in Patients With Solid Tumors Receiving Radiotherapy for Bone Metastases
Lead sponsor
Virginia Commonwealth University
Phase
Phase 1
Overall status
Terminated
Start date
August 31, 2011
Completion date
July 31, 2014
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, unspecified adult solid tumor, protocol specific